• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Geoffrey Smith

Stay informed with Geoffrey Smith’s coverage and analysis.

Inside The Toyota Megaweb Showroom Ahead Of Company Earnings
Toyota’s earnings shortfall adds insult to injury
By Geoffrey SmithAugust 4, 2015
Inside The American Electric Power Co. Coal-Fired Power Plant
Energy
Obama’s final emissions rule sets up a fight with states, GOP
By Geoffrey SmithAugust 4, 2015
Thomas 'Tom' Hayes, a former trader at banks including UBS Group AG and Citigroup Inc., leaves for lunch during for his trial at Southwark Crown Court in London, U.K., on Monday, Aug. 03, 2015. Hayes, the first person to stand trial for manipulating Libor, was found guilty of eight counts of conspiracy to rig the benchmark rate. Photographer: Simon Dawson/Bloomberg *** Local Caption *** Tom Hayes
Finance
Ex-UBS trader Tom Hayes gets 14 years for rigging Libor
By Geoffrey SmithAugust 3, 2015
Greek Nation Failed To Make Tangible Headway In Its Efforts To Secure Funding And Avoid A Default
Finance
Why Greece’s stock market just dropped more than 20%
By Geoffrey SmithAugust 3, 2015
HSBC Holdings Plc Headquarters And Bank Branches As Tax Scandal Threatens Chairman Douglas Flint
Finance
HSBC sells up in Brazil as compliance costs crimp global ambitions
By Geoffrey SmithAugust 3, 2015
FUSSBALL AUSRICHTER der FIFA WM 2018: RUSSLAND/ Putin und Blatter
Arts & Entertainment
Vladimir Putin thinks FIFA’s Blatter deserves a Nobel Prize
By Geoffrey SmithJuly 28, 2015
The Fed, GM and a Twitter update–5 things to know today
Features
The Fed, GM and a Twitter update–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 28, 2015
Petrol Prices At U.K. Gas Stations As Price Of Oil Continues To Fall
Energy
BP swings to $5.8 billion loss on Gulf charge, oil slide
By Geoffrey SmithJuly 28, 2015
GREECE-POLITICS-ECONOMY
Finance
Varoufakis’ Plan B was worse than a crime – it was half-baked nonsense
By Geoffrey SmithJuly 27, 2015
Inside Teva Pharmaceuticals Headquarters
Israeli drug firm Teva buys Allergan’s generics business for $40 billion
By Geoffrey SmithJuly 27, 2015
Fight against Daesh in Turkey's Syrian borderline
Features
ISIS and drug sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithJuly 24, 2015
CHINA-ECONOMY-STOCKS
Finance
China’s slowdown pushes commodity prices to new lows
By Geoffrey SmithJuly 24, 2015
Bottles of Johnnie Walker Scotch whisky and Smirnoff Vodka a
Retail
The SEC thinks Guinness brewer Diageo may be spiking its results
By Geoffrey SmithJuly 24, 2015
Wizard Of Oz
Arts & Entertainment
Europe’s antitrust regulators cry foul over Hollywood’s pay-TV deals
By Geoffrey SmithJuly 23, 2015
BofA Resolves Fannie Mae, Freddie Mac Loan-Putback Dispute
Features
Bank of America and Amazon earnings — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithJuly 23, 2015
1...
  • 72
  • 73
  • 74
  • 75
  • 76
...100
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.